GlassScriptPhysician profile
Eugene A Gulliver
NPI 1366401903
$8,241.22
in general payments reported to CMS, 2019-2025
14 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,340 · 2020: $2,214 · 2021: $40.19 · 2022: $275 · 2023: $461 · 2024: $3,592 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,379 · Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,378.77 |
| Food and Beverage | $1,993.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,247.09 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,727.16 | 2023-2024 | Corevalve Evolut R, In.Pact Admiral |
| Boston Scientific Corporation | $1,301.77 | 2019-2025 | Watchman Access System, Avvigo Guidance System |
| Biosense Webster, INC. | $467.72 | 2023-2025 | Carto 3, Qdot Micro Catheter |
| Chiesi USA, INC. | $176.68 | 2019 | |
| Daiichi Sankyo INC. | $78.98 | 2020-2023 | Injectafer |
| Abbott Laboratories | $62.07 | 2021-2024 | Aveir, Perclose Proglide |
| Kestra Medical Technology Services, INC. | $48.78 | 2023 | Assure Wcd |
| Cardiovascular Systems INC. | $30.70 | 2019 | |
| Livanova USA, INC. | $25.98 | 2022 | |
| Abiomed | $21.01 | 2025 | |
| Angiodynamics, INC. | $20.04 | 2021 | |
| Amgen INC. | $19.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Gulliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.